Oxford Spends $276MM for Four Life Science Assets, Including $75.6MM for One in Emeryville

(EDITOR'S NOTE: According to public documents reviewed by The Registry, the Emeryville property sold for $75,644,000.) Purchases three assets in Boston, one in Bay Area. Oxford will invest US$500 million through development of new biotech space and converting existing office and retail uses into new lab space at the Bay Area asset and value-add opportunities […]